The Vanderbilt Institute for Global Health, with Aminu Kano Teaching Hospital, will conduct a 60-site cluster randomized clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers with a five-year $5.9 million federal grant, “Bridging the Childhood Epilepsy Treatment Gap in Africa (BRIDGE),” from National Institute of Neurological Disorders and Stroke of the National Institutes of Health. Edwin Trevathan, M.D., M.P.H., Amos Christie Chair in Global Health, Professor of Pediatrics and

This week, VIGH hosted visitors from Nigeria's National Agency for Food and Drug Administration Control (NAFDAC) and the National Agency for the Control of AIDS (NACA) to attend the VIGH Transdisciplinary Program for Strengthening Clinical Trial Regulation Capacity. The goal of this program was to build capacity of NAFDAC and NACA staff for clinical trial regulation and oversight of clinical trial protocols. NAFDAC, Nigeria's local equivalent of the U.S.

               

Researchers at the Vanderbilt Institute for Global Health (VIGH) recently received a two-year, $895,072 grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health (NIH) to study whether an integrated, family-focused approach can prevent mother-to-child transmission of HIV—the AIDS virus—in Nigeria.

A team of Vanderbilt researchers recently received a $281,490 award from the National Institutes of Health (NIH) to fund a project studying stroke prevention among children with sickle cell disease in Nigeria.